Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) […]
Denodo Achieves Databricks Validated Partner Status for Its Seamless Integration in Support of AI and Analytics Leave a reply Working Together, Both Technologies Enable Greater Trust and Agility for Joint Customers PALO ALTO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Denodo, a leader in data management, announced that it has achieved the Databricks Validated Partner … Read more
iHerb Kicks Off Global Gifting Season with its Annual Black Friday and Cyber Monday Sales Event Leave a reply Wellness and Beauty Take Center Stage for Month-Long Promotions Featuring Discounts Starting at 20% Off iHerb Kicks Off Global Gifting Season iHerb, one of the world’s leading online retailers for health and wellness, launched its premier … Read more
SASE OpsLab Partners with Netskope to Revolutionize SASE Deployment at Scale for Frictionless Customer Experience Leave a reply Integration uses prepackaged automation to make large-scale SASE rollouts faster, easier, and inherently more secure through error-free tunnel orchestration DUBLIN, Nov. 12, 2025 (GLOBE NEWSWIRE) — UBiqube, the leader in multi-domain IT infrastructure orchestration and automation, today … Read more
NeOnc Technologies Reports Updated Clinical Results Leave a reply Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical … Read more
NeOnc Technologies Reports Updated Clinical Results Leave a reply Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical … Read more
NeOnc Technologies Reports Updated Clinical Results Leave a reply Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical … Read more
NeOnc Technologies Reports Updated Clinical Results Leave a reply Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical … Read more